Glyhill Trio 1 is a powerful combination therapy designed for effective management of type 2 diabetes mellitus containing Glimepiride (1 mg) Voglibose (0.2 mg) and Metformin hydrochloride (500 mg). Glimepiride promotes insulin secretion from the pancreas while Metformin enhances insulin sensitivity and reduces hepatic glucose production. Voglibose an alpha-glucosidase inhibitor slows the absorption of carbohydrates in the intestines helping to prevent post-meal blood sugar spikes. Together these components provide a multifaceted approach to blood sugar control assisting patients in achieving optimal glycemic levels and minimizing the risk of diabetes-related complications.
Glyhill Trio 1 (Glimperide Voglibose & Metformin hydrochloride (1mg/0.2mg/500mg)
Original price was: ₹95.00.₹35.00Current price is: ₹35.00.
Glyhill Trio 1 combines Glimepiride (1 mg) Voglibose (0.2 mg) and Metformin hydrochloride (500 mg) for effective management of type 2 diabetes and improved blood sugar control.
Add to cart
Buy Now
Reviews
There are no reviews yet.